MetaCap

Bambusa Therapeutics Inc. (BBTX)

NASDAQ: BBTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

16.00+0.45 (+2.89%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BBTX stock chart

Technical analysis

Key statistics

All statistics
Market cap
$815.08M
EPS (TTM)
-$1.73
52-week range
13.60 – 17.65
Day range
15.21 – 16.69
Volume / Avg
137.67K / 359.41K
Beta
—

52-week range

$13.60$17.65

BBTX stock today

Shares of Bambusa Therapeutics (BBTX) finished higher on Nov 20 at $16.00, a gain of 2.89% or $0.45 per share, versus the S&P 500's 3.70% decline. Trading was light, with 137.67K shares changing hands, about 38% of the average daily volume. At this level, BBTX sits in the middle of its 52-week range of $13.60 to $17.65: 9.3% below the high, set on Nov 11, 2026 and 17.6% above the low.

Bambusa Therapeutics has posted a net loss over the last twelve months (EPS of -$1.73), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Bambusa Therapeutics

Company profile

Bambusa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops long-acting bispecific antibodies for the treatment of immunological and inflammatory disorders. The company develops BBT001 for Type 2 inflammatory dermatological conditions, including atopic dermatitis, chronic spontaneous urticaria, and prurigo nodularis. It also develops BBT002, a long-acting bispecific antibody for respiratory and other Type 2 inflammatory diseases.

Industry
Biotechnology: Biological Products (No Diagnostic Substances)
CEO
Dr. Shanshan Xu M.B.A., M.D., Ph.D.
Headquarters
Boston, MA
Employees
26
IPO year
2026

Bambusa Therapeutics peers

Health Care sector
BBTX peer companies
CompanyPrice% ChgMarket capCompare
ODTXOdyssey Therapeutics Inc.16.96-7.52%$815.23Mvs BBTX
PRMEPrime Medicine Inc.3.55-7.55%$791.62Mvs BBTX
MGTXMeiraGTx Holdings plc7.98-1.97%$779.89Mvs BBTX
IMTXImmatics N.V.5.77-3.03%$878.58Mvs BBTX
GLUEMonte Rosa Therapeutics Inc.8.64-3.03%$738.29Mvs BBTX
AURAAura Biosciences Inc.6.87-1.58%$714.99Mvs BBTX
SLDBSolid Biosciences Inc.6.25-2.95%$697.57Mvs BBTX
ATTOAttovia Therapeutics Inc.15.10-3.08%$690.26Mvs BBTX

Indexes, lists and sector

Bambusa Therapeutics stock FAQ

What is Bambusa Therapeutics's stock price today?

BBTX last traded at $16.00 as of Nov 20, 4:00 PM EST, up 2.89% on the day. Prices are delayed at least 15 minutes.

Who is Bambusa Therapeutics's CEO?

Dr. Shanshan Xu M.B.A., M.D., Ph.D. is the chief executive officer of Bambusa Therapeutics Inc., which has about 26 employees.

What is the BBTX 52-week high?

The 52-week high for BBTX is $17.65 and the 52-week low is $13.60. The stock is currently 9.3% below its high.

Compare BBTX